CIK 0000894158 · Non-accelerated filer<br>Smaller reporting company
Theriva Biologics, Inc.
Sign in to watch- Ticker
- TOVX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 133808303
- Phone
- (734) 332-7800
- Business address
- 9605 MEDICAL CENTER DRIVE, SUITE 270, ROCKVILLE, MD, 20850
- Former names
- Synthetic Biologics, Inc., ADEONA PHARMACEUTICALS, INC., PIPEX PHARMACEUTICALS, INC., SHEFFIELD PHARMACEUTICALS INC, SHEFFIELD MEDICAL TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 35 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-08-30 | KUO JAMES S Chairman, CEO & President | Purchase | +4,500 | $0.69 | $3K | 4,500 |
| 2011-01-05 | Wolf Jeffrey Alan Director | Grant or award · Stock Options | +25,000 | 83,332 | ||
| 2011-01-05 | KANZER STEVE H Director | Grant or award · Stock Options | −25,000 | 304,391 | ||
| 2011-01-05 | Riley Jeffrey Scott Director | Grant or award · Stock Options | +25,000 | 58,333 | ||
| 2011-01-05 | Kraws Jeffrey J Director | Grant or award · Stock Options | +25,000 | 287,105 | ||
| 2010-12-02 | KANZER STEVE H Director | Grant or award · Stock Options | −8,333 | 279,391 | ||
| 2010-12-02 | Wolf Jeffrey Alan Director | Grant or award · Stock Options | +8,333 | 58,332 | ||
| 2010-12-02 | Riley Jeffrey Scott Director | Grant or award · Stock Options | +8,333 | 33,333 | ||
| 2010-12-02 | Kraws Jeffrey J Director | Grant or award · Stock Options | +8,333 | 262,105 | ||
| 2010-02-06 | KUO JAMES S Chairman, CEO & President | Grant or award · Options to purchase | +400,000 | 449,999 | ||
| 2009-12-22 | Wolf Jeffrey Alan Director | Grant or award · Option to purchase common stock | +8,333 | 49,999 | ||
| 2009-12-22 | Kraws Jeffrey J Director | Grant or award · Option to purchase common stock | +8,333 | 253,772 | ||
| 2009-12-22 | KUO JAMES S Chairman, CEO & President | Grant or award · Option to purchase | +8,333 | 49,999 |
Page 6 of 6 · 113 trades